Compass Capital Corp’s Amgen AMGN Stock Holding History

Compass Capital Corp’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-885	Closed	-$240K	–	178
2025 Q1	$240K	Buy	885 +15	+2%	+$4.43K	0.13%	157
2024 Q4	$227K	Buy	+870	New	+$258K	0.09%	186

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Compass Capital Corp's AMGN Position: Q2 2025 in Review

Compass Capital Corp sold out of Amgen (AMGN) in Q2 2025, closing a stake of 885 shares — an estimated $240K sold.

Compass Capital Corp first reported a position in AMGN in Q4 2024 and held it in 2 quarters. The position peaked at $240K in Q1 2025. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

Compass Capital Corp reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
Compass Capital Corp sold 885 Amgen shares in Q2 2025, an estimated $240K.
Compass Capital Corp first reported a position in Amgen in Q4 2024 and held it in 2 quarters.
Compass Capital Corp's Amgen position peaked at $240K in Q1 2025.
2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Compass Capital Corp's 13F filing for Q2 2025, filed 11 Aug 2025.